T C M. | STERLING BIOTECH | T C M./ STERLING BIOTECH |
|||
---|---|---|---|---|---|
P/E (TTM) | x | -14.8 | -0.0 | - | View Chart |
P/BV | x | 1.4 | 0.1 | 1,854.3% | View Chart |
Dividend Yield | % | 0.0 | 0.0 | - |
T C M. STERLING BIOTECH |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
T C M. Mar-23 |
STERLING BIOTECH Mar-18 |
T C M./ STERLING BIOTECH |
5-Yr Chart Click to enlarge
|
||
High | Rs | 58 | 7 | 858.2% | |
Low | Rs | 26 | 2 | 1,612.8% | |
Sales per share (Unadj.) | Rs | 9.8 | 12.7 | 77.5% | |
Earnings per share (Unadj.) | Rs | -5.7 | -36.9 | 15.5% | |
Cash flow per share (Unadj.) | Rs | -5.2 | -27.9 | 18.7% | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | 41.1 | 10.1 | 405.5% | |
Shares outstanding (eoy) | m | 7.48 | 272.17 | 2.7% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 4.3 | 0.3 | 1,296.8% | |
Avg P/E ratio | x | -7.4 | -0.1 | 6,501.4% | |
P/CF ratio (eoy) | x | -8.1 | -0.2 | 5,381.2% | |
Price / Book Value ratio | x | 1.0 | 0.4 | 247.9% | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 316 | 1,144 | 27.6% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 19 | 583 | 3.2% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 73 | 3,449 | 2.1% | |
Other income | Rs m | 0 | 55 | 0.4% | |
Total revenues | Rs m | 74 | 3,504 | 2.1% | |
Gross profit | Rs m | -37 | -7,582 | 0.5% | |
Depreciation | Rs m | 4 | 2,457 | 0.2% | |
Interest | Rs m | 3 | 4,397 | 0.1% | |
Profit before tax | Rs m | -43 | -14,381 | 0.3% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 0 | -4,327 | 0.0% | |
Profit after tax | Rs m | -43 | -10,054 | 0.4% | |
Gross profit margin | % | -49.9 | -219.8 | 22.7% | |
Effective tax rate | % | 0.5 | 30.1 | 1.8% | |
Net profit margin | % | -58.1 | -291.5 | 19.9% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 95 | 4,807 | 2.0% | |
Current liabilities | Rs m | 191 | 56,226 | 0.3% | |
Net working cap to sales | % | -130.8 | -1,490.7 | 8.8% | |
Current ratio | x | 0.5 | 0.1 | 580.3% | |
Inventory Days | Days | 191 | 1,685 | 11.3% | |
Debtors Days | Days | 2,331 | 543 | 429.0% | |
Net fixed assets | Rs m | 396 | 65,836 | 0.6% | |
Share capital | Rs m | 75 | 272 | 27.5% | |
"Free" reserves | Rs m | 233 | 2,486 | 9.4% | |
Net worth | Rs m | 307 | 2,759 | 11.1% | |
Long term debt | Rs m | 1 | 19,787 | 0.0% | |
Total assets | Rs m | 688 | 70,643 | 1.0% | |
Interest coverage | x | -14.6 | -2.3 | 641.4% | |
Debt to equity ratio | x | 0 | 7.2 | 0.0% | |
Sales to assets ratio | x | 0.1 | 0 | 218.7% | |
Return on assets | % | -5.8 | -8.0 | 72.5% | |
Return on equity | % | -13.9 | -364.5 | 3.8% | |
Return on capital | % | -13.1 | -44.3 | 29.5% | |
Exports to sales | % | 0 | 22.8 | 0.0% | |
Imports to sales | % | 0 | 0.6 | 0.0% | |
Exports (fob) | Rs m | NA | 785 | 0.0% | |
Imports (cif) | Rs m | NA | 21 | 0.0% | |
Fx inflow | Rs m | 0 | 785 | 0.0% | |
Fx outflow | Rs m | 16 | 26 | 60.1% | |
Net fx | Rs m | -16 | 759 | -2.1% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | -109 | -328 | 33.1% | |
From Investments | Rs m | 58 | -91 | -63.9% | |
From Financial Activity | Rs m | 49 | 384 | 12.7% | |
Net Cashflow | Rs m | -2 | -35 | 4.4% |
Indian Promoters | % | 49.5 | 24.6 | 200.9% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 7.7 | 21.9 | 35.2% | |
FIIs | % | 0.0 | 7.5 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 50.5 | 75.4 | 67.0% | |
Shareholders | 3,972 | 35,184 | 11.3% | ||
Pledged promoter(s) holding | % | 0.0 | 55.9 | - |
Compare T C M. With: PIDILITE INDUSTRIES SRF BALAJI AMINES YASHO INDUSTRIES ALKYL AMINES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | T C M. | Sterling Biotech |
---|---|---|
1-Day | 3.93% | -4.94% |
1-Month | 8.75% | 6.94% |
1-Year | 64.52% | -78.61% |
3-Year CAGR | 14.46% | -46.43% |
5-Year CAGR | 13.63% | -32.29% |
* Compound Annual Growth Rate
Here are more details on the T C M. share price and the Sterling Biotech share price.
Moving on to shareholding structures...
The promoters of T C M. hold a 49.5% stake in the company. In case of Sterling Biotech the stake stands at 24.6%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of T C M. and the shareholding pattern of Sterling Biotech.
Finally, a word on dividends...
In the most recent financial year, T C M. paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.
Sterling Biotech paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of T C M., and the dividend history of Sterling Biotech.
Indian share markets ended the mock trading session on a positive note tracking strong global peers and FII inflows.